Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways
- 28 June 2013
- journal article
- Published by Elsevier BV in Regulatory Peptides
- Vol. 185, 44-51
- https://doi.org/10.1016/j.regpep.2013.06.007
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac HypertrophyPLOS ONE, 2012
- ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite ProductionPLOS ONE, 2012
- Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with DiabetesPLOS ONE, 2012
- Vascular Remodeling in HypertensionHypertension, 2012
- Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular DysfunctionCirculation, 2011
- Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2Hypertension, 2011
- Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunitCardiovascular Research, 2011
- Profilin-1 Is Expressed in Human Atherosclerotic Plaques and Induces Atherogenic Effects on Vascular Smooth Muscle CellsPLOS ONE, 2010
- Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expressionBritish Journal of Pharmacology, 2008
- Upregulation of Angiotensin-Converting Enzyme 2 by All- trans Retinoic Acid in Spontaneously Hypertensive RatsHypertension, 2004